GENERAL MEDICINE: Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy

Audio Journal of Medicine, August 9th 2007 Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy REFERENCE: Lancet 2007; 370:39-48 MARGARET JOHNSON, Royal Free Hospital, London A new non-nucleoside reverse-transcriptase inhibitor has demonstrated its activity in patients infected with HIV-1. TMC125, or etravirine, was compared with placebo in over 500 treatment-experienced patients in the DUET-2 trial, and Derek Thorne heard more from Margaret Johnson of the Royal Free Hospital in London.